FDA is changing the therapeutic equivalence rating for Accord ...
FDA is concerned that the peak blood concentration of tacrolimus for Accord Healthcare Inc.’s generic tacrolimus oral capsules may be increased compared to the brand-name drug, Prograf...
Astellas Pharma US, Inc. Issues Voluntary Nationwide Recall of One …
Dec 24, 2024 · Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of PROGRAF® 0.5mg (tacrolimus) and one lot of ASTAGRAF XL® 0.5mg (tacrolimus ...
Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of ...
Dec 23, 2024 · Audience: Healthcare Provider, Pharmacy, Consumer. NORTHBROOK, IL, Dec. 23, 2024 – Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of Prograf® 0.5mg and one lot of Astagraf XL® 0.5mg (tacrolimus extended-release) capsules to the consumer level. These products are being recalled because bottles may contain empty capsules.
Astellas Pharma US, Inc. | News Room - News Releases
Dec 23, 2024 · FOR IMMEDIATE RELEASE – NORTHBROOK, IL, Dec. 23, 2024 – Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of PROGRAF® 0.5mg (tacrolimus) and one lot of ASTAGRAF XL® 0.5mg (tacrolimus extended-release) capsules to the consumer level.
Topical Tacrolimus Microemulsion May Be Effective for Scalp …
Mar 22, 2024 · Topical 0.1% tacrolimus-containing microemulsion may be efficacious and safe for patients with scalp psoriasis, according to study results published in Dermatologic Therapy. Over an 8-week period, investigators in Germany conducted a prospective, randomized, double blinded, placebo-controlled, phase 3 trial for the ScaTAC study group.
Tacrolimus news and latest updates - Medical Xpress
Study: Black kidney transplant patients exhibit faster clearance rates of key immunosuppressive medicine tacrolimus
TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus …
Jun 24, 2024 · TFF TAC delivers tacrolimus directly to the lung to yield improved lung immunosuppression at lower doses and systemic exposures compared to oral tacrolimus to improve efficacy and decrease ...
Volume 137: Hydrochlorothiazide, voriconazole, and tacrolimus
Nov 29, 2024 · Tacrolimus is a calcineurin inhibitor used in oral and intravenous formulations as an immunosuppressive medication to reduce the risk of rejection of solid organ transplants in adults and children, and to prevent graft-versus-host disease.
Tacrolimus - StatPearls - NCBI Bookshelf
Tacrolimus is a medication used in the prevention and treatment of solid-organ transplant rejection. It is in the calcineurin-inhibitor class of medications. This activity outlines the indications, action, and contraindications for tacrolimus as a valuable agent in preventing solid-organ transplant rejection (and other disorders when applicable).
Beneficial Effect of Tacrolimus… Cyclosporin A, Still up for …
Belli et al 1 published the first multicenter study that demonstrate a beneficial effect of tacrolimus. They described in a large multicenter study that included 243 adult symptomatic cases from 36 centers and 9 countries that the use of tacrolimus was associated with a better survival in liver transplant recipients.